Literature DB >> 12725112

Human prostate cancer cell lines.

Pamela J Russell1, Elizabeth A Kingsley.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12725112     DOI： 10.1385/1-59259-372-0:21

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN： 1543-1894


× No keyword cloud information.
  27 in total

1.  Combination of p53-DC vaccine and rAd-p53 gene therapy induced CTLs cytotoxic against p53-deleted human prostate cancer cells in vitro.

Authors:  H Saito; K Kitagawa; T Yoneda; Y Fukui; M Fujsawa; D Bautista; T Shirakawa
Journal:  Cancer Gene Ther       Date:  2017-06-16       Impact factor: 5.987

2.  Prostate-specific G-protein-coupled receptor collaborates with loss of PTEN to promote prostate cancer progression.

Authors:  M Rodriguez; S Siwko; L Zeng; J Li; Z Yi; M Liu
Journal:  Oncogene       Date:  2015-06-01       Impact factor: 9.867

3.  Comparative Secretome Profiling and Mutant Protein Identification in Metastatic Prostate Cancer Cells by Quantitative Mass Spectrometry-based Proteomics.

Authors:  Oh Kwang Kwon; Ju Mi Jeon; Eunji Sung; Ann-Yea Na; Sun Joo Kim; Sangkyu Lee
Journal:  Cancer Genomics Proteomics       Date:  2018 Jul-Aug       Impact factor: 4.069

4.  Metabolomics-based phenotypic screens for evaluation of drug synergy via direct-infusion mass spectrometry.

Authors:  Xiyuan Lu; G Lavender Hackman; Achinto Saha; Atul Singh Rathore; Meghan Collins; Chelsea Friedman; S Stephen Yi; Fumio Matsuda; John DiGiovanni; Alessia Lodi; Stefano Tiziani
Journal:  iScience       Date:  2022-04-07

5.  Bortezomib and etoposide combinations exert synergistic effects on the human prostate cancer cell line PC-3.

Authors:  Bekir Aras; Azmi Yerlikaya
Journal:  Oncol Lett       Date:  2016-03-16       Impact factor: 2.967

6.  Leucine-rich repeat-containing G protein-coupled receptor 4 (Lgr4) is necessary for prostate cancer metastasis via epithelial-mesenchymal transition.

Authors:  Weijia Luo; Peng Tan; Melissa Rodriguez; Lian He; Kunrong Tan; Li Zeng; Stefan Siwko; Mingyao Liu
Journal:  J Biol Chem       Date:  2017-08-02       Impact factor: 5.157

7.  SIRT5 Directly Inhibits the PI3K/AKT Pathway in Prostate Cancer Cell Lines.

Authors:  So Young Choi; Ju Mi Jeon; Ann Yae Na; Oh Kwang Kwon; In Hyuk Bang; Yun-Sok Ha; Eun Ju Bae; Byung-Hyun Park; Eun Hye Lee; Tae Gyun Kwon; Jun Nyung Lee; Sangkyu Lee
Journal:  Cancer Genomics Proteomics       Date:  2022 Jan-Feb       Impact factor: 4.069

8.  Impact of Fucosylation on Self-Assembly of Prostate and Breast Tumor Spheroids by Using Cyclo-RGDfK(TPP) Peptide and Image Object Detection.

Authors:  Regina-Veronicka Kalaydina; Hedi Zhou; Elena Markvicheva; Sergey V Burov; Farhana Zulkernine; Myron R Szewczuk
Journal:  Onco Targets Ther       Date:  2019-12-17       Impact factor: 4.147

9.  Paucity of PD-L1 expression in prostate cancer: innate and adaptive immune resistance.

Authors:  A M Martin; T R Nirschl; C J Nirschl; B J Francica; C M Kochel; A van Bokhoven; A K Meeker; M S Lucia; R A Anders; A M DeMarzo; C G Drake
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-08-11       Impact factor: 5.554

Review 10.  Prostate cancer metastasis: roles of recruitment and reprogramming, cell signal network and three-dimensional growth characteristics.

Authors:  Shabnam Ziaee; Gina Chia-Yi Chu; Jen-Ming Huang; Shirly Sieh; Leland W K Chung
Journal:  Transl Androl Urol       Date:  2015-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.